Assignee
KAROS PHARMACEUTICALS INC
US·4 granted patents·1 pending application·60 citations·filing 2014–2017
Top patents by PatentIndex Score
5 records- 0196US9199994B2Spirocyclic compounds as tryptophan hydroxylase inhibitorsKAROS PHARMACEUTICALS INC·Filed 2014·Granted Dec 1, 2015·31 cites·48 claims
- 0294US9750740B2Spirocyclic compounds as tryptophan hydroxylase inhibitorsKAROS PHARMACEUTICALS INC·Filed 2016·Granted Sep 5, 2017·14 cites·26 claims
- 0393US9512122B2Spirocyclic compounds as tryptophan hydroxylase inhibitorsKAROS PHARMACEUTICALS INC·Filed 2015·Granted Dec 6, 2016·15 cites·100 claims
- 0463US2017204041A1Processes for preparing (r)-1-(5-chloro-[1,1`-biphenyl]-2-yl)-2,2,2-trifluoroethanol and 1-(5-chloro-[1,1`-biphenyl]-2-yl)-2,2,2-trifluoroethanoneKAROS PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 0560US9611201B2Processes for preparing (R)-1-(5-chloro-[1,1′-biphenyl]-2-yl)-2,2,2-trifluoroethanol and 1-(5-chloro-[1,1′-biphenyl]-2-yl)-2,2,2-trifluoroethanoneKAROS PHARMACEUTICALS INC·Filed 2016·Granted Apr 4, 2017·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when KAROS PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →